Based in FAIRFAX, VA, LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER INC operates as a Public Charity. The organization reported $3.6M in revenue, $3.1M in expenses, $2.5M in total assets for fiscal year 2025.
THE MISSION OF THE LYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER (LDRTC) IS TO IMPROVE THE DIAGNOSIS, TREATMENT, AND UNDERSTANDING OF LYSOSOMAL AND OTHER RARE GENETIC DISORDERS BY CONDUCTING SCIENTIFIC RESEARCH, ADVANCING TRANSLATIONAL MEDICINE, EDUCATING HEALTHCARE PROFESSIONALS AND PATIENTS, AND PROMOTING THE DEVELOPMENT OF INNOVATIVE THERAPIES.
How Lysosomal and Rare Disorders Research and Treatment Center Inc divides every $100 it spends, from its own Form 990 filings, averaged across 6 years.
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $3.6M | $3.1M | $2.5M |
| 2024 | $4.4M | $3.7M | $2.4M |
| 2023 | $3.4M | $3.7M | $1.9M |
| 2022 | $3.0M | $2.5M | $2.1M |
| 2021 | $2.7M | $2.1M | $1.6M |
Between 2021 and 2025, reported annual revenue grew from $2.7M to $3.6M (+36%), with total assets most recently reported at $2.5M.
Interactive year-over-year charts and full filing details available with membership.
